Description

Key Characteristics

• Dual-incretin mechanism, engaging both GIP and GLP-1 pathways
• Frequently referenced alongside single-pathway GLP-1 compounds in comparative metabolic research
• Long-acting profile supports extended-interval dosing schedules in research protocols

Primary Research Focus Areas

• Appetite and satiety signaling
• Glycemic control
• Body composition and weight management
• Comparative incretin-pathway research

Preparation & Storage

• Reconstitute with bacteriostatic water; dissolve gently without shaking
• Store unreconstituted powder at -20°C
• Refrigerate reconstituted solution at 2–8°C; use within 30 days

Research Chemical: NOT FOR HUMAN CONSUMPTION. For laboratory research and in vitro use only. Not FDA approved.